Kayt Sukel
Kayt Sukel publishes mostly in Economics and Econometrics, General Health Professions and Immunology, on topics such as Pharmaceutical Economics and Policy, Healthcare Policy and Management and Biosimilars and Bioanalytical Methods.
- World rank
- #7,705,047 of 7,710,434 ranked researchers
- Rank in United States
- #1,625,901 of 1,627,098
- Works
- 157
- Citations
- 38
- Citations per work
- 0.2
What does Kayt Sukel research?
Kayt Sukel's work is mostly in Economics, Econometrics and Finance (18%), Medicine (8%), Health Professions (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else9459.7%
- Social Sciences3320.8%
- Economics, Econometrics and Finance2918.2%
- Psychology42.6%
- Health Sciences2314.5%
- Medicine127.6%
- Health Professions116.9%
- Life Sciences85.0%
- 1Economics and Econometrics18% of their works
- 2General Health Professions7% of their works
- 3Immunology5% of their works
- 4Public Health, Environmental and Occupational Health4% of their works
- 5Radiology, Nuclear Medicine and Imaging3% of their works
- 6Clinical Psychology3% of their works
Research topics
- Pharmaceutical Economics and Policy
- Healthcare Policy and Management
- Biosimilars and Bioanalytical Methods
- Health Systems, Economic Evaluations, Quality of Life
- Artificial Intelligence in Healthcare and Education
- Pharmaceutical industry and healthcare
- Pharmaceutical Practices and Patient Outcomes
- Biotechnology and Related Fields
Which keywords describe Kayt Sukel's research?
The keywords of their largest research topics: Pharmaceutical Industry, Drug Development Costs, Generic Drugs, Health Care Spending, Insurance Markets, Biosimilars, Immunogenicity and Cost-effectiveness Analysis.
- Polypharmacy
- Health Biotechnology
- Conflict of Interest
- Artificial Intelligence
- Cost-effectiveness Analysis
- Biosimilars
- Health Care Spending
- Drug Development Costs
- Pharmaceutical Industry
- Generic Drugs
- Insurance Markets
- Immunogenicity
- Quality of Life
- Machine Learning
- Global Collaboration
- Inappropriate Medication Use
- Research Outcome
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 17 words, with their numbers
- Pharmaceutical Industry262 topics
- Drug Development Costs211 topic
- Generic Drugs211 topic
- Health Care Spending161 topic
- Insurance Markets161 topic
- Biosimilars151 topic
- Immunogenicity151 topic
- Cost-effectiveness Analysis141 topic
- Quality of Life141 topic
- Artificial Intelligence71 topic
- Machine Learning71 topic
- Conflict of Interest51 topic
- Global Collaboration51 topic
- Health Biotechnology51 topic
- Inappropriate Medication Use51 topic
- Polypharmacy51 topic
- Research Outcome51 topic
Where does Kayt Sukel work?
Kayt Sukel's main affiliation in the publication record is ING Direct, United States.
How many publications and citations does Kayt Sukel have?
OpenAlex counts 157 works and 38 citations for Kayt Sukel, an h-index of 3, ranking #7,705,047 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kayt Sukel. Posts are plain text and can be reported.